Time point | Screening < 2 weeks | Baseline Day 0 | Visit 3 Month 11 | Visit 4 Month 32 | Visit 5 Month 6 | Visit 6 Month 9 | Visit 7 Month 122 |
---|---|---|---|---|---|---|---|
Informed consent | X | Â | Â | Â | Â | Â | Â |
Record demographics & handedness | X | Â | Â | Â | Â | Â | Â |
Review inclusion/exclusion criteria | X | X | Â | Â | Â | Â | Â |
Review medical history | X | X | Â | Â | Â | Â | Â |
Details of stroke | X | Â | Â | Â | Â | Â | Â |
Pre stroke function (inc Oxford Handicap Scale)) | X | Â | Â | Â | Â | Â | Â |
Abbreviated Mental Test Score (AMTS) | X | Â | Â | Â | Â | Â | Â |
Sheffield Aphasia Screening Test | X | Â | Â | Â | Â | Â | Â |
Action Research Arm Test (ARAT) | X | X | X | X | Â | Â | X |
Motricity Index | Â | X | X | X | Â | Â | X |
Grip strength | Â | X | X | X | Â | Â | X |
Nine Hole Peg Test | Â | X | X | X | Â | Â | X |
Modified Ashworth Scale | X | X | X | X | Â | Â | X |
Self rating of severity | Â | X | X | X | Â | Â | X |
Upper limb pain (numerical rating scale)3 | Â | X | X | X | Â | Â | X |
Patient selects upper limb goals | Â | X | Â | Â | Â | Â | Â |
Review upper limb goal attainment | Â | Â | X | Â | Â | Â | Â |
Barthel ADL Index3 | X | Â | X3 | X3 | Â | Â | X3 |
Quality of life – Stroke Impact Scale3 | X |  | X3 | X3 |  |  | X3 |
Quality of life – Euroquol-5D3 | X |  | X3 | X3 |  |  | X3 |
Resource utilisation questions3 | X | Â | X3 | X3 | Â | Â | X3 |
Pregnancy test4 | Â | X | Â | X6 | X6 | X6 | Â |
Randomisation | Â | X | Â | Â | Â | Â | Â |
Treatment with Dysport5 | Â | X | Â | X7 | X7 | X7 | Â |
Commencement of 4 week upper limb therapy programme | Â | X | Â | X7 | X7 | X7 | Â |
Clinical assessment by study therapist | Â | X | Â | X | X | X | X |
Concomitant medications (inc anti-spasticity treatment) | X | X | X | X | Â | Â | X |
Adverse Events | Â | X | X | X | Â | Â | X |
Participants views and experience | Â | Â | X | Â | Â | Â | X |